Navigation Links
Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
Date:2/4/2008

Deal follows positive phase I data from novel product candidate AM103 for

the oral treatment of respiratory disease

SAN DIEGO, Feb. 4 /PRNewswire/ -- Amira Pharmaceuticals and GlaxoSmithKline today announced they have entered into a worldwide exclusive agreement to develop, manufacture and commercialize FLAP (5-Lipoxygenase Activating Protein ) inhibitors for the treatment of respiratory and cardiovascular disease.

Under the terms of the agreement GSK will be granted an exclusive, worldwide license to develop, manufacture and commercialize Amira's FLAP inhibitors, including AM103 and other compounds within the current development program. In the event that all potential development and regulatory milestones are successfully achieved, Amira could receive up to US $425 million in upfront and milestone payments. In addition, Amira will be entitled to receive tiered royalty payments based on worldwide net sales and commercial sales milestones.

Initial development activities will focus on candidate compound AM103, for the treatment of asthma. Positive data, from a phase I study completed in November 2007, show AM103 has the potential as a once-daily, oral, non-steroidal asthma treatment. In this study the compound was also well-tolerated.

Peppi Prasit, Chief Scientific Officer and Co-Founder Amira said: "To have identified such a positive drug candidate and progressed to the completion of phase I clinical trials just two years after the company was founded is a tremendous achievement for the team at Amira. We are delighted that GlaxoSmithKline will be taking this asset into full development. With their experience and expertise in this area we hope that AM103 will become the first FLAP inhibitor available to patients worldwide to treat symptoms of asthma and possibly other inflammatory diseases."

"This is a momentous day in the young life of Amira," said Bob Baltera, Chief Executive Officer, Amira. "This deal valid
'/>"/>

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Amira Pharmaceuticals Appoints First Vice President of Development
2. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
3. Poniard Pharmaceuticals Announces Upcoming Conference Participation
4. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
5. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
6. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
7. Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors
8. Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
9. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Final Cut Pro X plugin specialists have ... Film Studios. , “The TranStatic Volume 2 plugin gives users ... CEO of Pixel Film Studios. “TranStatic Volume 2 is a ... editors toolbox.” , With TranStatic Volume 2 users can transition ... scrambling effects from Pixel Film Studios. Users have total control ...
(Date:3/1/2015)... As residents and business owners in Southlake, ... Carita Weaver, believe in supporting local organizations and ... Chamber of Commerce, Carroll Independent School District and ... website for Southlake mayoral candidate Laura Hill: ... Hill’s campaign, the website combines images, videos and ...
(Date:3/1/2015)... March 01, 2015 Adults who are ... rates for term or universal policies can now use ... the best life insurance companies for single adults can ... at http://quotespros.com/life-insurance.html . , The rate plans that ... are tied to a number of life protection policies. ...
(Date:3/1/2015)... York, NY (PRWEB) March 01, 2015 ... has grown substantially over the past few weeks in ... LLP are actively filing claims, the Firm announces. ... reflects 7,713 cases in the Bergen County proceeding established ... Inc., compared with a few weeks earlier, when 90 ...
(Date:3/1/2015)... 2015 Theme and plugin developers from ... pack for Final Cut Pro X entitled Transccordion. ... to any FCPX editors project.” Said Christiana Austin, CEO ... tools needed to easily drag and drop their accordion ... many different controls over the parameters of this transition ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2
... N.J., April 1, 2008 Defined Health has,announced ... for its 8th,annual Therapeutic Insight conference. Therapeutic Insight ... 30, 2008, at The Westin New York at ... registration information,along with content and attendee statistics from ...
... Association of,Health Plans (OAHP), the statewide trade association of ... Ohioans, announced the,election of new officers this week., ... chair of OAHP.,Crampton is the Chair of the Board ... serving the Ohio CFC Medicaid program in,the Northwest and ...
... 1, 2008 Core People Resources,today announced a ... Wexford, PA. CCSC provides options in healthcare coverage ... chamber members through,its ChamberChoice portfolio., The partnership ... level of employer services, including comprehensive human resource,outsourcing ...
... 2008 Leading consumer,employer and labor organizations ... physician groups and health insurers on principles,to ... and report the,information to consumers., The ... Tiering Programs" announced today creates a national ...
... Turns Assets from Retirement Plans Into Guaranteed Income ... ... NEW YORK, April 1, 2008 AXA Equitable Life,Insurance ... new variable annuity -- Crossings(SM): My Lifetime,IRA(SM), designed specifically as ...
... Acomplia might help fight coronary disease , , TUESDAY, April 1 ... not help slow atherosclerosis, a buildup of arterial plaque that,s ... trial did not find any evidence that the drug actually ... one measure of plaque build-up in arteries. , Acomplia ...
Cached Medicine News:Health News:Shannon Brownlee, Author of 'Overtreated,' to Keynote at Defined Health's 8th Annual Therapeutic Insight Conference 2Health News:Ohio Association of Health Plans Announces New Officers 2Health News:Core People Partners to Expand Services 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 2Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 3Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 4Health News:Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 2Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 3Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 4Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 6Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 7Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 2Health News:Obesity Drug Shows Mixed Success Against Atherosclerosis 3
(Date:3/2/2015)... , March 2, 2015 Cardinal Health ... business, a leading global manufacturer of cardiology and endovascular ... billion, net of the present value of tax benefits. ... combination of $1.0 billion in new senior unsecured notes ... expected to close in the United States ...
(Date:3/2/2015)... DUBLIN , March 2, 2015   ... device businesses for a total consideration of up to $1.65 ... Endo also evaluating strategic alternatives for AMS, Women,s Health ... into a global specialty pharmaceuticals business ... today announced it has entered into a definitive agreement with ...
(Date:3/2/2015)... WOODLANDS, Texas , March 2, 2015   ... a biopharmaceutical company focused on developing breakthrough treatments for ... end 2014 financial results on Wednesday, March 4, 2015 ... a conference call and webcast to discuss clinical development ... year end of 2014 at 10:00 a.m. Eastern Time ...
Breaking Medicine Technology:Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 2Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 3Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 4Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 5Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 6Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 7Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 2Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific 3Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2
... Academy of Neurology Annual Meeting,Show Approximately 50 ... 01, 2007 /PRNewswire/ -- Data from two ... of Neurology (AAN),meeting suggest that an investigational ... is effective as add-on,treatment in patients with ...
... Sleep Interference, INDIANAPOLIS, May 03, 2007 /PRNewswire-FirstCall/ -- ... that in patients with pain,caused by diabetic nerve ... Cymbalta (duloxetine HCl), improvements in,both average daily pain ... sleep interference than in those patients,taking sugar pill. ...
Cached Medicine Technology:New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 2New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 3New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 4New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6
... The Modular Shoulder System* ... surgeons with a comprehensive range ... of individual patient needs. With ... Smith + Nephew offers a ...
... The Bio-Modular, for ... shoulder replacement. Modularity in ... range of sizing and ... with one of the ...
... The Bigliani/Flatow shoulder allows for the ... cases of shoulder replacement surgery. Backed ... and decades of experience, the Bigliani/Flatow ... the natural shoulder's mobility, balance, and ...
Comprehensive, unified system for total or hemi shoulder arthroplasty....
Medicine Products: